DelveInsight’s pharmaceuticals report, “Avonex PS - Drug Insights, 2014” provides Avonex PS marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report is built using data and information sourced from DelveInsight proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by DelveInsight team of industry experts.

Data SourcesThe report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.

Scope - A review of the Avonex PS based on information derived from company and industry-specific sources - Coverage of the Marketed data of the Avonex PS on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification - Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Schizophrenia drugs with location details - Patent Expiry Timeline and Exclusivity Details - Route of Synthesis of the API - Global Forecasted Sales Figure from 2011-2015 - Qualitative and quantitative assessment of market space - SWOT Analysis

Reasons to buy - Evaluate the marketing status and exclusivity details of Avonex PS to exploit opportunities for generic drug development opportunities. - Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Avonex PS. - API intelligence over Avonex PS and gaining primary intelligence over Active Ingredients manufacturers across the globe. - Understanding the chemical route of synthesis of Avonex PS. - Uncovering opportunities in the rapidly growing the US market - Stay ahead of competition by understanding the changing competitive landscape - Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential - Make more informed business decisions from insightful and in-depth analysis of the drug’s performance - Obtain sales forecast for currently marketed drug for 2011-2015

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the European cance ...

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...